Use of p53 transgenic mice in the development of cancer models for multiple purposes.
about
Optimization of the optical transparency of rodent tissues by modified PACT-based passive clearingNNK-Induced Lung Tumors: A Review of Animal Model.Epigenetic effects and molecular mechanisms of tumorigenesis induced by cigarette smoke: an overviewAnimal models in carotenoids research and lung cancer prevention.Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities.Mouse models incorporating alterations in the major tumor suppressor genes P53 and P16: their use in screening for potential carcinogens, developing further relevant mouse models, and screening for potential chemopreventive and chemotherapetutic ageToxicology and carcinogenesis study of senna in C3B6.129F1-Trp53 tm1Brd N12 haploinsufficient mice.Review paper: the role of inflammation in mouse pulmonary neoplasia.Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K.A further review of inhalation studies with cigarette smoke and lung cancer in experimental animals, including transgenic mice.Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer.Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA.
P2860
Q30833287-FF36A22D-8FF6-4AF3-ADBC-A17EAB748E09Q34928737-904C9735-28FA-47A8-870D-6B588E9CAB22Q34928808-1DFFBFC5-6F33-4A22-9A85-C7EF033755F5Q35182584-B3728E46-6AFE-43E5-A249-67925CD21B1AQ35882119-5D7F1D07-FDD3-4FD8-B91D-60A44A8B09CCQ36070444-A11DD82B-FF28-41AD-8B36-577610B46FF1Q36901854-1C8CE308-0299-47BC-9CEE-A13443C4A8B6Q37379547-D101A663-9176-4131-94C0-E8B6999E0161Q37607199-C665452C-391F-4CD4-83C8-504A80CEBA8FQ37779103-C3C4BB14-EC9E-41F2-9B3D-D7E0A78A723EQ44084966-512CEC81-88A7-49E9-954C-F1800BC690A3Q44588836-45F82EA7-7D69-4F47-B3BA-0B2C442B9B13Q46772699-B2CDBA80-330F-465F-8908-AA3A1EAF0E52Q46773108-7FED1791-69F0-44CC-9C44-3B3E4C143715
P2860
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@ast
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@en
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@nl
type
label
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@ast
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@en
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@nl
prefLabel
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@ast
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@en
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@nl
P2093
P1476
Use of p53 transgenic mice in the development of cancer models for multiple purposes.
@en
P2093
P304
P356
10.1080/01902140150216684
P577
2000-12-01T00:00:00Z